Healthcare
Mr. Stern is Managing Director and Head of the firm’s Healthcare Group, specializing in Mergers & Acquisitions, Capital Raising and Valuations/Fairness Opinions. With over 25 years’ experience, Mr. Stern has worked with early-stage companies to multi-billion dollar conglomerates in healthcare services, healthcare IT (HCIT), medical products & supplies and nutraceuticals, as well as medical device and biopharmaceutical companies.
Mr. Stern is the leading investment banker in the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMA of NJ and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, and the sale of Santa Monica Fertility to Webster Equity Partners.
Before joining Dresner Partners, Mr. Stern was a Managing Director in Healthcare Investment Banking at Morgan Joseph. He has also held positions with SMH Capital (Sanders Morris Harris), Glocap Advisors, Needham & Co., Schroders plc (Wertheim Schroder), and Salomon Brothers. In addition, Mr. Stern worked for the M&A Transactions Group at Deloitte & Touche and was a Certified Public Accountant (C.P.A.) with Ernst and Whinney (now Ernst & Young).
M.B.A. Finance, New York University
B.A. Accounting, Franklin and Marshall College
